News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Americans rate Seattle one of safest cities in Gallup poll
Seattle is viewed by Americans as one of the safest cities in the country, according to a recent poll from Gallup. The survey involved roughly
Curi Bio lands over $4.4M in NIH grants for two projects
Curio Bio, a Seattle-based biotech company, received $4.4 million from the National Institutes of Health. The funding will be used to support two projects, one
Seattle biotech startup Talus Bio awarded $4.3 to fight cancer
Talus Bioscience, a Seattle-based biotech, received $4.3 million from the Washington Andy Hill Cancer Research Endowment Fund and the National Institutes of Health. The grant
Kundig-designed life science proposal lands at Interbay
A new life science building is set to be built in Seattle’s Interbay neighborhood, overlooking Terminal 86 and shouldering Expedia’s headquarters. The building is nearly
Seagen’s breast cancer therapy succeeds in late-stage study
Bothell-based biotech company Seagen found success with one of its breast cancer therapies on Wednesday. A combination of the treatment, named Tuksya, met the goal
AGC Biologics, Asahi Kasei Enter Clinical Drug Substance Agreement
AGC Biologics, a biotech company headquartered in Bothell, is partnering with pharmaceutical company Asahi Kasei to develop a drug substance that will support antibody therapies.
Absci and Caltech Collaborate to Accelerate Affordable HIV Therapeutic Vaccine
Absci, a biotech firm based in Vancouver, Washington, received a grant from the Bill & Melinda Gates Foundation to fund its partnership with the California
Seattle company founded by Nobel Prize winner plans human tests for experimental COVID-19 drug
Seattle biotech company Cocrystal Pharma received permission from regulators to begin early-stage clinical trials for its COVID-19 and norovirus treatments. Previously, the company focused on
Behind the Code: Humanizing Data Science at Bristol Myers Squibb
Julie Rytlewski has always loved math and medicine. As a teenager, she taught herself to code, built her own computer and developed a passion for
AAHI lands $18M award from the NIH
Access to Advanced Health Institute, a biotech nonprofit based in Seattle, received an $18 million grant from the National Institutes of Health. The funding will
After tech contraction, WA still has more jobs than job seekers
Washington’s labor market has remained strong amidst national tech layoffs and indicators of a recession. According to the Bureau of Labor Statistics, high hiring rates
Phase Genomics lands $2.5M in fresh funding
Phase Genomics, a Seattle-based biotech company, secured $2.5 million in funding from the National Cancer Institute and the Andy Hill Cancer Research Endowment (CARE) Fund